Osteoarthritis is one of the most common reasons for which a person experience a chronic pain and disability and for which he may compel himself to undergo hip replacement, medical experts say. Hip replacement by DePuy Orthopeadic, a unit of Johnson & Johnson, ASR Hip Systems, may have been the cause of the 10,100 lawsuits it is facing now after its recall hip implants were being reported as defective. Its artificial hip implants endangered the lives of its recipients due to metallosis that caused many health problems. As a matter of fact, a dePuy director gave an internal report indicating nearly 40 percent ASR failure rate.
Osteoarthritis is a form of arthritis that occurs when cartilage on the end of bones starts to wear out, triggering pain and stiffness. When the cartilage totally wears off, the bones rub directly to each other, reducing the mobility of a person because the pain on the joints is already unbearable. When this occurs, a person starts seeking surgery such as hip replacement with the hope that it will take the pain away and restore his normal mobility and help him get back with the life where it had last taken off. Unfortunately, it was not the case of thousands of recipients worldwide.
Developing metallosis is the number one problem that concerns recipients of the hip implant. It is also known as metal poisoning -- the shredding off metal ions from the implants which runs the risk of getting into the bloodstream, resulting in several illnesses.
One way of evaluating whether a person is suffering from metallosis is when he has difficulty walking, sitting, standing for a long time due to extreme pain on the hip implant area. It may be looked and proven when the person undergoes a blood test to check the level of metal toxicity.
Hip replacement surgery involves replacing components of the hip joints with a synthetic implant. It guarantees patients renewed stability and function. Moreover, it may help ease the pain, make the patient’s hip joints work better, and restore normal walking and other movements,
For some people, hip replacement constituted a decision that they regretted, for which many lives went through many dilemmas and discomfort -- an opposite expectation for which hip implant had offered in the first place.
After thousands of patients worldwide claimed the hip implant design was defective, DePuy Orthopeadics carried out a voluntary recall in 2010, costing them $800 million in two years and plunging them into loses for the DePuy hip recall. For more related cases, check the DePuy Recall News Center at depuyrecallnewscenter.com.